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The recent Pennsylvania Medical
Society's 1992 Leadership Conference,
"Survival on the High Wire," provided
a forum for discussion of a wide range
of interesting topics on the current
medical landscape. These included a .
look at evolving trends in several areas
of health care, including liability
reform, managed care of all different
types, and a considerable amount of
interest in the development of practice
parameters and clinical outcomes
research.
Cost containment continues to be the
main focus of those paying for medical
care, with increasing attention directed
toward evaluation of treatment
outcomes and effectiveness. Much
discussion at the meeting centered
around the future of American health
care. Emphasis was placed on the
importance of physician-hospital
relationships and the need to form
effective partnerships, in an era of
increasing control by the purchasers
and regulators of our services.
The significance of practical political
involvement for physicians, and the
need to develop a working relationship
with our legislators was also stressed.
It is clear that rapid change in health
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care is the order of the day, and the
more proactive we are the better we
will be able to deal with the new
environment.
Several tapes from the meeting
presentations have been requested and
are available in the Medical Staff
Services Office. The tapes include
"Practice Parameters," "Liability
Reform" (excellent), and "The Future
of Health Care."
Progress continues on the Cancer
Center with an advisory committee
including a number of Medical Staff
members helping to shape the exact
form of the Center and its leadership.
Gary Marshall, Administrator,
Oncology Services, has recently been
hired. In addition, a physician director
of the Cancer Center will be selected
via a search process, considering both
internal and external candidates.
The Past Presidents Council continues
to meet regularly. This is a new
committee which has been very helpful
in providing perspective and the benefit
of past leadership experience in
addressing current problems of the
Medical Staff.
Continued on Page 2

Continued from Page 1

Many of you have expressed concern
about the new OSHA Guidelines for
physicians' office practices. In
conjunction with our Infection Control
Department, Physician Office Practice
Services (POPS) recently conducted
seminars for office staffs to provide
assistance and direction in attempting
to comply with these sometimes arcane
directives from our friends in
Washington.
We are seeing increased interest in
serving on the Medical Executive
Committee including a number of
inquiries on how one gets to serve.
Basically, there are a total of 12 atlarge members of the committee of
whom four are nominated and elected
each year in June. The term is three
years with meetings held once a
month.

Observation Status
On April 10 at 17th & Chew and April
17 at Cedar Crest & I-78, the
outpatient category of Observation
status became available for use. The
goals of this outpatient category are to
reduce admission denials and provide
additional time and setting to evaluate
patients prior to a decision to admit the
patient. Key points for physicians to
remember:

*
*

a physician's order must be
written to assign patients to
Observation
documentation in the medical
record must clearly reflect the
reason the patient required
Observation

While the issues dealt with are
sometimes difficult and complicated,
the payback is that Medical Staff
members get a chance to participate in
the decision and policy-making
processes of our hospital as well as a
more in-depth look at the governance
process here. Service on the Medical
Executive Committee, although
sometimes demanding, can be a very
rewarding experience. Expressions of
interest should be communicated to the
Medical Staff Services Office either
personally or in writing.

Jaffe, M.D.
President, Medical Staff

*

decisions to admit or discharge
patients should be made within
24 hours from the time of the
order to assign patient to
Observation

*

physician billing and hospital
billing must be the same -OUTPATIENT

*

consultations should be handled
on a physician-to-physician
basis and should be responded
to within four hours.

If you have any questions regarding
appropriate use of Observation, please
contact Susan Lawrence, Director,
Integrated Quality Assessment/
Resource Utilization Management, at
778-2414.
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Notification of Reportable
Cases to the Coroner

*

Deaths known or suspected as due to
contagious disease and constituting a
public hazard (refer to Policy in the
Infection Control Manual under
Reportable Diseases - Infection'Control
Policy, Section ll- Isolation).

*

Sudden Infant Death Syndrome (SIDS)

*

Stillbirths that are 16 weeks of gestation
or greater, and death of infants within
24 hours of birth.

It is the policy of Lehigh Valley

Hospital to abide by Pennsylvania Law
16 P.S. s5106, which requires the
proper notification of reportable cases
to the Coroner. According to the
guidelines, this law provides immunity
from civil and/or criminal liability
arising out of reporting. Failure to
report any of these cases can lead to
civil or criminal liability.
The following are reportable cases
under Pennsylvania Law to the
Coroner:

*

Sudden deaths, as defined below, not
caused by readily recognizable disease,
or wherein the cause of death cannot be
properly certified by a physician on the
basis of prior (recent) medical
attendance.

*

Death occurring under suspicious
circumstances, including those where
alcohol, drugs or other toxic substances
may have had a direct bearing on the
outcome.

*

Deaths occurring as a result of violence
or trauma (including falls), whether
apparently homicidal, suicidal or
accidental (including, but not limited to,
those due to mechanical, thermal,
chemical, electrical or radiational injury,
drowning, cave-ins and subsidences).

*

Any death in which trauma, chemical
injury, drug overdose or reaction to
drugs or medication or medical
treatment, was a primary or secondary,
direct or indirect, contributory,
aggravating or precipitating cause of
death.

*

Operative and peri-operative deaths in
which the death is not readily
explainable on the basis of prior disease.

*

Any death wherein the body is
unidentified or unclaimed.

Sudden Death - The Coroner shall
regard any death as sudden if it occurs
without prior medical attendance by a
person who may lawfully execute a
certificate of death in this
Commonwealth, or if, within 24 hours
of death, the decedent was discharged
from such medical attendance or a
change of such medical attendance had
occurred, or if any such medical
attendance began within 24 hours of
death and the medical attendant refuses
or is unable to certify the cause of
death. Medical attendance includes
hospitalization.
For more information, please consult
Policy Number AD 2100.02 in the
Administrative Directory which is
available in Medical Staff Services.

Page 3

One Hospital - One
Telephone Exchange
Another important step in the merger
of the hospital will take place on June
1 -- one unique telephone exchange for
the entire hospital system.
Currently, the hospital uses several
telephone exchanges including 776,
778, 821, 798, to name a few. On
June 1, Lehigh Valley Hospital will
begin using the 402 prefix which will
be used solely by the hospital.
Although the change will benefit the
public in terms of simplicity, it should
cause little to no confusion for
employees and affected physician
offices. An important part of the
conversion is that the four digit
extensions following the new prefix
will remain unchanged. Also
unchanged will be some of the typical
codes such as "99" for outside lines
and Ext. 8999 for the paging operator.

Differences to the system will be
minor, such as dialing "5100" rather
than "51" for direct paging; "5300"
rather than "53" to change paging
status; and "9000" rather than "0" to
access the inside operator.
Because 10,000 numbers are affected,
it is impossible for Bell of
Pennsylvania to provide after-the-fact
recordings indicating the change for
everyone's extension.
However, newspaper advertising
regarding the new telephone exchange
will run in local newspapers throughout
the month of May to alert the
community. In addition, physicians'
offices affected by the new exchange
have received postcards to notify their
patients of the change.
The new telephone exchange is the
latest in a series of actions designed to
give Lehigh Valley Hospital a truly
singular identity.

Single Provider Number
Anticipated
Since the announcement of the
hospital's new name -- Lehigh Valley
Hospital-- physicians' offices have
inquired if the hospital now has a
single provider number. According to
Sandra Colon, Director of Patient
Accounting, Lehigh Valley Hospital
has made application for a single
hospital provider number, and it is
expected that this request will be
approved. In addition, a single number
for Medicare billing and
reimbursement is also being pursued.

The anticipated date for change is July
1, 1992, and, if granted, the hospital
will use the former Allentown Hospital
provider number as its single provider
identification. Since physicians may
need to update their billing systems
with this change, updates and
announcements will be provided
through Medical Staff Progress Notes
as soon as information becomes
available.
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Any questions or comments regarding
this test should be addressed to Brian
W. Little, M.D., in Pathology.

HLA Testing
The Histocompatibility (HLA) Lab at
Lehigll Valley Hospital, Cedar Crest &
I-78, has been in operation for over a
year and provides to the medical
community of the Lehigh Valley and
surrounding area unique clinical testing
opportunities. In addition to servicing
the renal transplant program, the HLA
Lab offers testing which may be of
value to physicians in the areas of
hematology, oncology, rheumatology,
ophthalmology, and endocrinology.
For your convenience, attached to this
issue of Medical Staff Progress Notes
is a table which briefly outlines the
HLA tests which are currently
available along with some of the
clinical applications for each test.

DNA Ploidy
Measurements
The Clinical Laboratory is pleased to
announce that DNA ploidy
measurements of solid tumors are now
available. The testing is done on
paraffin embedded tissue by flow
cytometry. Image analysis technology
is also available for smaller specimens
and for specific morphometric
measurements.
Test requests received by Tuesday will
be reported on Friday. The test must
be requested by ordering on the
surgical pathology request form or by
calling the molecular lab at 776-8005.

Intact-PTH
Through an agreement with
Nephrology and Endocrinology, the
Laboratory is promoting the IntactPTH as the most reliable clinical test
for parathyroid hormone. Thus, theNterminal and C-terminal tests have been
removed from the new laboratory test
request form. The Intact-PTH is done
in-house by an RIA method and
requires a lavender top tube and a red
top tube placed on ice and delivered as
soon as possible to the laboratory. The
test request, besides an Intact-PTH,
includes an ionized calcium,
phosphorus, and creatinine. Please
refer to the Laboratory Handbook for
reference ranges. If you have any
questions regarding this issue, please
contact Gerald E. Clement, Ph.D.,
Director, Toxicology/Immunology/
Chemistry, at 778-2534, or Gale
Fritch, Immunology Supervisor, at
778-2845.

Tay Sachs Testing
Thomas Jefferson University, the
hospital's reference lab for Tay Sachs
testing, has recently instituted a charge
for this test; therefore, effective June
1, patients will no longer receive Tay
Sachs screening for free. There will
now be a $60 charge for the testing.
Test results received from Thomas
Jefferson will be mailed by the
laboratory directly to the patient and/or
ordering physician. If you have any
questions regarding this issue, please
contact Dr. Clement at 778-2534 or
Gale Fritch at 778-2845.
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Library Computerized
Services - What's New
The new year has brought with it many
new additions and changes to the
library's computerized services. Since
there will be much more to come, now
is the time to familiarize yourself with
these services and how to utilize them.
Computer technology and information
management is changing almost daily;
therefore, the methods and programs
used in the library will be undergoing
changes just as rapidly. If you are
already using these services, it is
important that you keep current with
these changes as they occur.
Information is always available in the
library or by calling Sherry
Giardiniere, Computer Coordinator, at
776-8406.

Recent Changes

very useful by the host system have
been eliminated. If you are a current
remote user and are experiencing
problems, please contact Mrs.
Giardiniere at 776-8406 for assistance
and further information. All new
information and documentation will be
sent out as soon as possible after the
changes occur.
If you do not currently utilize this
service but would like to, orientations
will be held monthly beginning in June
1992. Contact Mrs. Giardiniere for
hardware and software requirements.

ILIAD 4.0
Iliad, a computer-based medical
diagnostic tool for internal medicine,
has been upgraded to version 4.0
which contains significant
enhancements. This program is
available 24 hours daily at Cedar Crest
&I-78. This is an exciting new way
to use computers in medicine, and we
will see much more happen in the area
of expert systems in the future. There
is a demo available on the system;
training and orientation are being
planned for the near future.

Medline Remote Access
Because of a conflict between the new
1992 set of MEDLINE CD's and the
library's communications remote access
software PC ANYWHERE III, an
update to the new PC ANYWHERE
4.5 version has been made. There are
major changes in this upgrade which
affect some of the methods used by the
remote user. Although there is more
flexibility with the upgrade, it requires
some users to change their methods of
access. Also, features found to be
Page 6

Nuclear Medicine News
The Nuclear Medicine Division at
Lehigh Valley Hospital', Cedar Crest &
I-78, has recently purchased a state-ofthe-art Scinticor multi-crystal gamma
camera for the evaluation of right
ventricular and left ventricular wall
motion and ejection fraction. This new
camera has both first pass and
multigated capabilities and can be used
portably if indicated. It is anticipated
that portable use of this camera will be
mostly on the patients in the Open
Heart and Transitional Open Heart
units on whom echocardiograms would
be very difficult to obtain.

*

If you are mainly interested in
the ejection fraction of both
ventricles, please order an
IIRNA-RVEF & LVEF 11 scan.
A routine first pass RNA scan
will be performed.

*

If you are interested in both
wall motion and ejection
fraction of the left ventricle,
please order 11 RNA-LVEF with
wall motion. 11 An anterior first
pass RNA scan followed by a
LAO gated cardiac scan will be
performed.

*

If you are interested in both
wall motion and ejection
fraction of the right and left
ventricles, please order "RNARVEF & L VEF with wall
motion. 11 An anterior first pass
RNA scan followed by a LAO
gated cardiac scan will be
performed.

*

If you are interested in
myocardial viability, please
order a gated MIBI scan. This
study may also be done portably
if needed.

All of the Nuclear Medicine physicians
and technologists have been fully
trained on this equipment and can
provide this service on a same day or
next day basis.
When ordering this examination, please
specify the following:

*

Whether or not the study needs
to be done portably.

*

If you are mainly interested in
the ejection fraction of the left
ventricle, please order an
IIRNA-LVEF 11 scan. A routine
first pass RNA scan will be
performed.

IV Therapy Update and
Procedural Changes
In an effort to provide members of the

Medical Staff with the most up-to-date
information, attached to this issue of

If you have any questions or comments
regarding this issue, please contact one
of the Nuclear Medicine physicians at
776-8383.

Medical Staff Progress Notes are
details regarding critical issues related
to IV Therapy as well as recent policy
and procedural changes.
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Pool Trust Approves
Funding
f

The Trustees of the Dorothy Rider
Pool Health Care Trust recently
approved the release of $98,000 of
Department of Medicine Discretionary
Funds to John P. Fitzgibbons, M.D.,
as Chairman, Department of Medicine.
The funds will be used to support the
research activities within the
Department of Medicine.
The Trustees have also approved
release of $211,951 of Trust funds
from the Institutional Research grant
for the following RAC protocols:
"Trauma Outcome Neurophysiology
Study (TONS): Assessment of the
Prognostic Significance of Selected
Neurophysiological and Clinical Data
in Severely Head Injured Patients" $102,657- Alexander Rae-Grant,
M.D., Principal Investigator (PI)
"The Role of MRI in the Diagnosis of
Foot Infections in the Diabetic" $28,275- Gary Nicholas, M.D., PI
"Nonlinear Dynamics of Neurological
Events: Electroencephalography" $26,840 - Alexander Rae-Grant, M.D.,
PI

Medical Staff Progress Notes is published
monthly to inform the Lehigh Valley
Hospital Medical Staff and employees of
important issues concerning the Medical
Staff. Articles should be submitted to
Janet M. Laudenslager. Coordinator.
Physician Office Practice Services. 17th
& Chew. by the first of each month. If
you have any questions regarding the
newsletter. please call Ms. Laudenslager
at 778-2780.

"Cellular Models of
Hypoxic/Ischemic/Traumatic Brain
Insult: Mechanisms and Treatments" $25,725- George Chovanes, M.D., PI
"Herpes Simplex Virus and OroTracheal Airways" - $13,920 - Patrick
Hanley, D.O., PI
"Health-Related Quality of Life in
Inflammatory Bowel Disease" $10,034- James Reed ill, Ph.D., PI
"Clostridia Difficile Colitis" - $4,500 Lester Rosen, M.D., PI
The Pool Trustees also initiated two
Innovation and Development grants -the first one, "Lehigh Valley
Partnership for Health: Access to
Care, Phase ll" for $10,000 to
facilitate collaboration among the
health and human services providers in
Lehigh and Northampton Counties, and
the second, "The Generalist
Physician," for $5,000 to be used to
facilitate the Lehigh Valley Hospital's
role in Hahnemann University's
development of primary care.

Our Quality Policy: Our commitment is to
quality in everything we do. This can
only be achieved if we provide services
that conform to clearly understood
requirements. We are dedicated to
continuous improvements in our work
processes. Our approach is based on
"Prevention" and the concept of "Do it
right the first time."
Equal Opportunity Employer
M/F/H/V
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Exclusive OSHA
Resources Available to
Pennsylvania Medical
Society Members
New Occupational Safety and Health
Administration (OSHA) regulations on
bloodborne pathogens affect virtually
every Pennsylvania physician in
clinical practice, with few exceptions,
and failure to comply could cost
thousands of dollars per violation.
An information kit has been created by
the Pennsylvania Medical Society to
provide members with everything
necessary to comply with the new
regulations, including:

•

a Model Exposure Control Plan
reprinted, with permission, from the

•

an Employee Training Manual also
published by the AMA;
an overview of the final OSHA
regulations and compliance requirements
for the office;
an informative article on the regulations
reprinted from the April issue of
Pennsylvania Medicine; and
a one-page summary of the phase-in
dates for the new requirements.

•
•
•

AMA;

The kit is available to members only
for $10 plus tax. For order
information, contact the Pennsylvania
Medical Society, Department of
Physician Services, at 1-800-228-7823.

Congratulations!
Gazi Abdulhay, M.D., Department of
Obstetrics and Gynecology, and his
wife, Sue, welcomed a baby daughter
on April 28. Nour weighed 7 lbs.
4 1/2 oz., and was 20 in. long. She
was welcomed home by her two
sisters, Leyla and Mediha, and three
brothers, Ali, Nabil, and Amir.
Howard A. Israel, M.D., allergist,
was recently informed that he
successfully passed the certification
examination and is now a Diplomate of
the American Board of Allergy and
Immunology.
Francis A. Salerno, M.D., chief,
Division of Geriatrics, was recently
honored by the Medical Alumni of
Saint Joseph's University with the
prestigious Clarence E. Shaffrey, S.J.
Award.

Father Shaffrey, who served as
Professor of Biology for over 20 years
at St. Joseph's, was directly
responsible for establishing what is
today recognized as one of the finest
pre-medical departments in the United
States. His greatest ambition was
realized in blending the office of a
priest and the educating of Catholic
men for the medical profession. His
devotion as a teacher to his students
was exceeded only by his dedication to
the service of God. It is for this
profound dedication of himself and his
untiring efforts in the preparation of
young men for the medical and dental
professions that this award is made.

Page 9

Publications, Papers and
Presentations
Bala B. Carver, M.D., pathologist,
co-authored an article, Subacute
(Acute, Persistent) Thrombotic
Thrombocytopenic Purpura (TTP),
which was presented at the 13th
Annual Meeting of the American
Society for Apheresis which was held
recently in Chicago, ill.
Peter A. Keblish, M.D., chief,
Division of Orthopedic Surgery, was
principal exhibitor for a scientific
exhibit at the American Academy of
Orthopaedic Surgeons 59th Annual
Meeting, held in Washington, D.C.
The title of the exhibit was "Rationale
and Selection of Prosthetic Types in
Mobile Bearing Total Knee
Arthroplasty. 11 Michael J. Pappas,
Ph.D., a biomedical engineer from the
New Jersey Institute of Technology,
was co-exhibitor. Dr. Keblish also
presented a scientific paper at the Foot

and Ankle Society meeting during the
AAOS meeting, titled "Cementless
Meniscal Bearing (Shallow Sulcus)
Total Ankle Replacement:
Multicenter Clinical Trial of 237."

Indru T. Khubchandani, M.D., colon
and rectal surgeon, recently served as a
visiting professor at San Pietro
Hospital, University· of Genoa, Italy,
where he lectured on "New Trends in
Surgery for Crohn's Disease" at the
faculty meeting.
He was also an invited speaker at the
Second International Symposium on
Advances in Colon and Rectal Surgery
in Torino, Italy, and was the keynote
speaker at the opening ceremony with
an address, "Status of Coloproctology
in the World." He also lectured on
"Emergency Surgery in Colon
· Diseases 11 and participated in a panel
and showed a video on
"Hemorrhoidectomy with Local
Anesthesia."

Upcoming Seminars,
Conferences, and
Meetings

Medical Grand Rounds
Parting Shots will be presented by
John H. Samies, M.D., infectious
disease specialist, on Tuesday, May
19.

Medical Grand Rounds are held each
Tuesday beginning at noon in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & I-78.

Magnesium will be presented by Mark
D. Kelley, M.D., general internist, on
Tuesday, May 26.

For more information, contact the
Department of Medicine at 776-8200.
Continued on Page 11
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Department of Pediatrics
Grand Rounds will be held on
Tuesday, May 19, and on Tuesday,
May 26, both beginning at 8 a.m., in
the Auditorium of Lehigh Valley
Hospital, 17th & Chew.
Approach to the Adolescent Patient How Do You Deal With
Confidentiality with Teenagers will
be presented by Paula Braverman,
M.D., Adolescent Medicine, St.
Christopher's Hospital for Children, on
Friday, May 22, beginning at noon.
Dorsal Rhizotomy will be presented
by Ann-Christine Duhaime, M.D.,
pediatric neurosurgeon, on Friday,
May 29, beginning at noon.
Both noon conferences will be held in
the Auditorium of Lehigh Valley
Hospital, 17th & Chew.
For more information, contact Beverly
Humphrey in the Department of
Pediatrics at 778-2540.

Department of
Psychiatry to Begin
Grand Rounds in June
The Department of Psychiatry has
developed a Grand Rounds series
scheduled for the third Thursday of
each month. The hour-long sessions
will begin at noon.
The first Psychiatry Grand Rounds
program, New Insights into the
Neurobiology and Treatment of
Depression and Anxiety from PET
Research, will be presented by Wayne
C. Drevets, M.D., Assistant Professor

of Psychiatry, Washington University
School of Medicine, St. Louis, Mo.,
on June 18 in the Auditorium of
Lehigh Valley Hospital, 17th & Chew.
Dr. Drevets' presentation will include
three sections: functional brain
imaging techniques, regional
abnormalities in affective and anxiety
disorders, and neuroanatomical circuits
related to depression.
As lunch will be provided, preregistration is requested. For more
information or to register, please call
Lisa in the Department of Psychiatry at
778-2810 by June 1.

Primary Care Seminars
Issues in Blood Banking will be
presented by Ronald E. Domen, M.D.,
Medical Director, Miller Memorial
Blood Center, on Wednesday, May 20,
from 10 a.m. to noon, in the
Auditorium of Lehigh Valley Hospital,
17th & Chew.
How to Quit Smoking - The Role of
the Primary Care Physician will be
presented by John A. Kibelstis, M.D.,
pulmonologist, and Sam Bub, M.D.,
family practitioner, on Wednesday,
June 10, from 10 a.m. to noon, in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & 1-78.
Detection and Treatment of Allergic
Rhinitis will be presented by Diane
Schuller, M.D., on Wednesday, June
17, from 10 a.m. to noon, in the
Auditorium of Lehigh Valley Hospital,
17th & Chew.
For more information, contact the
Department of Medicine at 776-8200.
Continued on Page 12
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Regional Symposium
Series lll
Seventh Annual Postgraduate Course
in Obstetrics and Gynecology will be

held on Friday, June 5, from 7:30a.m.
to 5 p.m., at the Holida:,; Jr.nBethlehem, Routes 512 and 22,
Bethlehem, Pa. At the completion of
this program, participants will be able
to discuss the management of diabetes
during pregnancy, describe the
management for post caesarean section
bleeding, discuss the diagnosis and
treatment of HIV infection in women,
identify the incidence and treatment of
Group B streptococcus in pregnancy,
explain the pathophysiology of
hirsutism, describe techniques used in
preventing adhesions after gynecologic
surgery, discuss the diagnosis and
treatment of pelvic mass, and describe
the most current surgical management
of cervical cancer.
Obstetricians, gynecologists, family
practitioners, oncologists, nurses, and
other healthcare professionals
interested in an update in maternal-fetal
medicine, reproductive endocrinology,
and gynecologic oncology will benefit
from the program.
For more information, please contact
Human Resource Development at
776-8322.

Alzheimer's Disease:
When Life Becomes a
Puzzle
The Division of Geriatrics, in
conjunction with Hospital Central
Services, Inc. and Subsidiaries, will

offer a comprehensive, one-day
seminar about Alzheimer's Disease on
Wednesday, June 10, at the Scottish
Rite Cathedral, 1533 Hamilton Street,
Allentown, from 8 a.m. to 4:30p.m.
Information about the latest research on
Alzheimer's Disease, early symptoms
and how to manage difficult behavior,
and community resources to help cope
with caring will be presented at the
seminar.
The $12 registration fee covers the cost
of parking, lunch, and program
materials. For more information,
please contact Patricia Brill, M.S.W.,
Ambulatory Geriatric Evaluation
Services, at 778-9890.

Shopping for a Physician
Office Practice System?
Results of a survey conducted last year
of physician offices on the hospital's ·
Medical Staff indicated that
approximately 50% of the respondents
to the survey were not yet automated
and that almost half of these offices
plan to automate in the near future. In
order to assist physician offices with
office automation planning and as a
continuation of the Introduction to
Computers series which was offered to
physicians during the last three months,
a three-hour seminar regarding how to
select a physician office practice
system has been scheduled.
·The seminar, which is open to
members of the Medical Staff and their
office managers, will be held on
Thursday, June 4, from 7 to 10 p.m.,
at Lehigh Valley Hospital, Cedar Crest
& I-78, in the Quality Room on the
third floor of the Carl Anderson Wing.
Continued on Page 13
Page 12

Continued from Page 12

The program will include discussion of
an 11-step process for selecting a
system, benefits analysis, and
operational and implementation
considerations. Although strengths and
distinguishing features of the major
vendors servicing the Lehigh Valley
area will be covered, vendor
endorsements will not be made since
no one vendor is the right choice for
every office.

The seminar is a joint effort of the
hospital's Information Services
Department and Physician Business
Services, Inc. Session size is limited
and pre-registration is required. To
register, please contact Pat Skrovanek,
Physician Office Practice Services
(POPS) representative, at 778-2781.

Physician Practice
Opportunities
*For Sale or Lease-- MedicalProfessional Office Building on Cedar
Crest Boulevard, just minutes from
Cedar Crest & I -78 and 17th & Chew.
Plenty of parking. Ideal for physician.
* For Sale or Lease -- Springhouse
Professional Center, 1575 Pond Road.
Ideal for physician's office. Two
suites available -- one with 2,540 sq.
ft. ; one with 2,514 sq. ft. Will finish
space to specifications.
* For Sale or Lease -- Medicalprofessional office building on South
Cedar Crest Boulevard, just minutes
from Cedar Crest & I-78 and 17th &
Chew. 3 ,5 60 total sq. ft. Ample
parking, security/fire alarms installed.
Ideal for physician group.
* For Sale -- Professional Office
Building on West Broad Street, near
the Allentown/Bethlehem border.
4,500 sq. ft. with plenty of parking on
corner lot.

*For Lease --Slots are currently
available for the Brown Bag suite at
Kutztown Professional Center.
* For Lease -- Share large medical
office near Cedar Crest & I-78. Fully
furnished and staffed. Multiple line
phone system. Computerized billing
available.
* For Lease -- Specialty practice timeshare space available in a
comprehensive health care facility.
Riverside Professional Center, 4019
Wynnewood Drive, Laurys Station.
Half- or full-day slots immediately
available.
* For Lease -- Share medical office
space at Riverside Professional Center
in Laurys Station. Ideal for solo or
small group practice.
For more information, contact Joe
Pilla, POPS Representative, at
778-9647.
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WHO'S NEW
The Who's New section of Medical
Staff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,
etc.
Please remember that each department
or unit is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

Medical Staff

Allied Health
Professionals
Appointments
Barbara Koons, CRNP

Physician Extender
Professional - CRNP
(17th & Chew- Clinic)

Carol B. Laurenzano, PsyD

Additional Privileges

Associate Scientific
Psychologist
(Department of Psych~atry)

Richard M. Lieberman, :MD

Additional Privileges

Department of Surgery
Division of Urology
Laparoscopic Endoscopic Surgery

Paul L. Orr, :MD

Department of Psychiatry
Electro-Convulsive Therapy

David S. Glosser, SeD
Associate Scientific
Psychologist
Psychology Privileges

Change of Status
Laura S. Kramer, DO

Department of Medicine
Division of Internal Medicine
Section of General Internal Medicine
From Provisional Active to Provisional
Courtesy

Edward A. Schwartz, DPM

Department of Surgery
Division of Orthopedic Surgery
Section of Podiatry
From Active to Referring

JohnS. Wheeler, :MD

Department of Pediatrics
Division of General Pediatrics
From Active to Courtesy
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P & T HIGHLIGHTS

I
I

Lehigh Valley Hospital Pharmacy Department

I

James Giardina, R.Ph., M.S. - Editor

-J

The following actions were taken at the April 13, 1992 P & T
Committee meeting.

PARENTERAL ANTIBIOTIC ORDER PROGRAK

The Committee vas informed that one month compliance with the new
order sheet ranged between 70 and 90X on a daily basis.
Costs
were $20,000 less in March when compared to the average of
January and February, 1992.
An ad hoc group discussed
reorganizing the order form sequence in patient charts to reduce
the likelihood of missed orders.
More will follow on this topic.

THE PRESCRIPTION COSTS WHAT!

Through the first 6 month of FY 92 <July-December 91>, we spent 1
million dollars more on drugs compared to the same period in the
previous fiscal year.
The causes for the increases were noted to
be:
- New products, especially biotech agents
- Increased utilization of existing products.
- Excessive price increases from manufacturers (i.e. > 10Y./yr>
The committee approved a plan to specifically deal with the
pharmaceutical industry which includes:
- Mandatory registration at Pharmacy for all visits to the
hospital.
Restriction on in hospital detailing to formulary meds only.
Negotiat& favorable terms with those companies passing on large
increases.
Privilege suspension for companies failing to comply with
visiting and detailing requirements.

Strategies to assess effectiveness and to control inappropriate
utilization will be developed and brought to the committee at a
future date.
Strategies discussed include a Counter Detailing
Program, Physician Education and Pharmacy and Therapeutics
Committee Restructuring.

THE AHSWER TO TOO KUCH TYLENOL IS ••

The Committee approved several recommendations to reduce the
potential for Chronic Acetaminophen <APAP> toxicity.
Again the
source of the potential problem is the concurrent use of several
different APAP containing products for analgesia/antipyresis.
Recommendations are:
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1.

Educate <Physician/Nurses> regarding the maximum recommended
dose (< 4 Gm/day> and APAP content of the major products:
Product
Acetaminophen Tablet
Acetaminophen Xtra Strength
Acetaminophen w/Codeine
<Tylenol w/Codeine>
Acetaminophen w/Oxycodone
<Percocet>
Acetaminophen w/Propoxyphene
<Darvocet N 100)
Acetaminophen/Butalbital/Caffeine
<Fioricet>

2.
3.
4.

S.

APAP Content
32Smg
S00mg
300mg
32Smg
650mg
32Smg

Review preprinted order sheets to assess need for multiple
agents.
Add a cautionary statement to not exceed 4Gm/day on
preprinted orders which have multiple acetaminophen
containing products.
Inform major prescribing physicians that Oarvocet N 100 has
never been proven to be more effective than ASA or APAP, has
greater side effects and is addictive. This will be done
through a pharmacy counter detailing program.
Develop recommendations on appropriate pain management.

HEPARIN INFUSION STANDARD
The Committee agreed that Pharmacy will only stock one
concentration of Therapeutic Heparin for continuous infusion the 25,000 units/250cc size.
Physicians need only write orders
for Heparin infusion @ xxx units/hr.
Whenever concentrations
other than 2S,000units/2S0cc are ordered, a pharmacist will
contact the prescriber to suggest the standard in order to
decrease the potential for misinfusion due to rate calculation or
dispensing errors.
DRUG USE EVALUATIONS
The Committee accepted reports on usage of Clozapine and
Alteplase <tPA>.
Key findings were as follows:
Clozapine - Most criteria were met for the 11 courses <10 pta>
followed.
Criteria needing improvement were weekly CBC
monitoring, side effects and concomitant hematologically toxic
meds.
The ·evaluation will be repeated.
- As with Clozapine, most criteria were met for the 28
courses reviewed.
Continued monitoring focusing on dose
prescribed <relative to wt. > and order turnaround time will be
performed.

Altepl~se

FORKULARY ADDITION REQUESTS
C1arithromycin <Biaxin. Abbott> - this request was tablet pending
further review and recommendations by the I.D. Section.

Page 16

ftivacuriu• (ftivacron, B-W> - is the shortest acting nondepolarizing neuromuscular blocker marketed to date.
It is
indicated as an adjunct to general anesthesia, to £acilitate
intubation and to provide skeletal muscle relaxation when
required.
Blockade occurs is 2-6 minutes, with average time to
25X and 95X recovery being 16 and 26 minutes, respectively.
The
most common reported adverse ef£ect is flushing o£ the face, neck
and chest <17X>.
Dosage varies depending on concomitantly
administered agents, depth of anesthesia required, patient age,
patient response, renal and hepatic status.
Mivacurium costs
$8.12/10mg and $l2.69/20mg vial.
Pamidronate <Aredia, Ciba-Geigy> - is an intravenous
biphosphonate derivative indicated to treat hypercalcemia o£
malignancy.
The most common side e£fects are transient fever and
leucopenia, which occur within the first two days o£ therapy.
Mild thrombophlebitis has also been reported £requent1y.
Pamidronate is contraindicated in patients allergic to any
biphosphonate.
The recommended dose £or moderate hypercalcemia
<corrected serum calcium o£ 12-13.5mg/dL> is 60-90mg, and in
severe hypercalcemia <correctea serum calcium> 13.5mg/dL> is
90mg.
Pamidronate is given as a single, 24 hour in£usion.
Once
reconstituted, Pamidronate should be diluted in 1000cc DSW, NaCl
0.45X or 0.9X.
It should not be diluted in any calcium
containing solutions <Lactated Ringers, Ringers, etc.>.
A
limited number of patients have been retreated with Pamidronate
and the manufacturer recommends waiting at least 7 days to allow
£or £ull response.
See chart below for cost comparison.
Galliu• Nitrate <Ganite, Fujisava> - was also added to the
£ormulary as an alternative agent to treat more severe £orms o£
hypercalcemia.
There is little published data comparing Gallium
to either etidronate or pamidronate and the committee agreed that
a task £orce should be appointed to make recommendations on
treatment strategies.
Gallium can cause adverse renal ef£ects
<increased BUN and Creatinine> and should not be given
concurrently with other potentially nephrotoxic agents (e.g.
aminoglycosides, amphotericin B>.
Gallium is contraindicated in
patients with severe renal impairment <SCr > 2.5mg/dL>.
The
usual recommended dose o£ gallium is 200mg/m 2 daily for 5
consecutive days.
The daily dose should be diluted in 1000cc o£
NaCl 0.9Y. or DSW and given over 24 hours.
Adequate hydration
must be maintained throughout the treatment period with careful
attention to avoid over hydration in cardiovascular compromised
patients.
Cost Comparison £or Pa•idronate, Etidronate, Gallium Nitrate
Unit Cost

Extended Cost

Pamidronate 30mg

$134.75

$269.50 <60mg)-$404.25 (90mg>

Etidronate 300mg

$ 54.83

$328.98 <600mg/day x 3 doses>

Gallium Nitrate
500mg/20ml

$ 91.30

$456.50 (1 vial/day x 5 days>
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Etidronate <Didronel, Horwich) - was deleted from the formulary
since all indications are that Pamidronate is safe, more
effective and easier to administer.
Hicotine Transdermal Syste• <Various brands, various •£g. ) - was
approved to the formulary for a 4 month therapeutic evaluation as
a smoking cessation aid.
The various patches differ slightly in
size and dose per patch.
All patches were found to be more
effective when used in conjunction with a behavior modification
program, with long term results unimpressive when used alone.
The most popular brands come in 21mg, 14mg and 7mg per 24 hr
patch.
Common side effects are local skin irritation under the
patch <25-50X>.
Nicotine patches are contraindicated in patients
allergic to any of the components of the patch.
Therapy is
started with a 21mg patch unless the patient weighs less than
100lbs, is a light smoker or has cardiovascular disease.
Once
therapy is initiated, patients should stop smoking completely.
Patients should be transferred to 14mg patches after 4-8 weeks,
then to 7mg after 2-4 weeks and stop using patches and be
nicotine free after 2-4 additional weeks.
DOCTOR, I WANT THE HEW ONCE DAILY CARDIZEK OR LETS PROTECT OUR
PROFITS.
Diltiazem <Cardizem CD, Marien-Merrell Dow> was discussed by the
committee.
The point that this is one of the most heavily
patient promoted products in recent years cannot be ignored.
The advertized advantages are of course patient convenience and
savings compared to the SR dosage form.
What the ads don't say
is that the SR patent has expired and any company could
manufacturer it and would probably do so less expensively than
Marion.
The committee agreed that Pharmacy will:
- Stock and dispense only the 300mg CD strength.
- Dispense 90mg SR BID for 180mg CD daily orders.
- Dispense 120mg SR BID for 240mg CD daily orders.
Both substitutions will be made with a note to the chart changing
the order.
This decision, will be re-evaluated depending on
generic SR availability and/or Marion's decision to stop making
SR sooner.

pt\41392.hi
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DRUG INFORMATION BULLE.flN
Lehigh Valley Hospital
May, 1992
I

Edltor: Mary· E. Bradley

NEW I.V. CLEANROOM:

On March 30, 1992, the Lehigh Valley
Hospital Pharmacy Departn"lent received
authorization from the State Health Departn"lent to occupy and begin compounding
operations in the ne"\-Vly constructed
pharmacy cleanroom located in the main
pharmacy, CC & 1-78, on the first floor. The
cleant'oon"l provides a class 10,000 positive air
pressure environment for the laminar air
flo"\oV hoods "\oVhich are used to compound
patient I.V. solutions, parenteral nuta'ition,
and syringes. Adjacent to the cleanrootn is
an ante-room "\-Vhich is used for go"\oVning a~d
staging of compounding operations. Pharmacy personnel are required to "\oVear O;R.
greens, caps, foot covers, and gloves prior to
entering the cleanroorn. With this ne"\-V
" yility, the Pharmacy Department
\......-gin to expand the I.V. admixture services
offered to our patients at both campuses.

will

By: Lynn Kuster, Supervisor, Sterile Products

PEPTIC ULCER -Combination Treatment?

Perhaps you are already familiar '\vith our
physician chart notice for therapeutic
duplication in patients receiving combination
therapy for the tt•eatment of' pt'opltylaxis of
peptic ulcers. Combination therapy for
peptic ulcer disease "vould be justified if a
reduction in ulcer heating time Ot' an inCt'ease in pet'centage of ulcers healed "\-Vas
rea1ized. Yet, despite the theoretical advantages of pt'escribing agents "\-Vith differing
r·nechanistns of action, literature to support
the use of coanbination thet•apy is lacking. In
fact, there are disadvantages to prescribing
multiple medications for peptic ulcer disease.
These indude inct'eased cost, vvhich may be
prohibitive to patients vvithout prescription
· yment plans; complicated adtninistration
h .. <~iedules, vvhich may affect patient compliance; and the potential for drug-drug inter-

ac+.;,.."'ls. Therefore, vvithout proven ad,·antages, and vvith the existence of a number of
disadvantages, combination therapy does not
offet• increased efficacy over tnonothet·apy.
For this reason, single-drug regimens remain
the mainstay of therapy.

WHICH ANTIBIOTIC?

Recently, with the advent of O\lf' newly
instituted parenteral antibiotic order sheet
(PAOS1 many questions have been asked.
One of the tnore frequently encountered
queries is:"Where did cefoxitin (Mefoxin) go?"
Cefazolin/Metronidazole and Cefot.etan
at"e ne"v additions to our antibiotic forn"lulary and have appeat..ed, alternath·ety to
c:efoxitin, on the P AOS. Ovving to sitnilar
activity, cefazolin/metronidazole and
cefotetan have been sho"\oVn to be as effective as cefoxitin in surgical prophylaxis and
vvould be appt•opriately used in infections
vvhere a mixed aerobic-anaes'obic flora is
encountered. Cefazolin/metronidazote is the
most cost effective of the three agents '-Vit.h
its lin"litation being its contraindicated use in
pregnancy.
this setting, cefotetan "\-Vould
be the suggested alternative. Cefotetan has
not been approved fof' use in pediatrics,
thef'efoa·e, it is fof' this population only that
vve recommend cefoxitin.

In

Daily Cost

Considerations

Dosing
Schedule

Cefazolin/
Metronidazole

$8.28

avoid in pregnancy

q8h

Cefotetan

$17.50

not recommended tor
pediatrics

q12h

Cefoxitin

$24.56

advise against routine use
in adults due to cost
consider at ions

q6h

* Cefotetan needs only be given q12h due to its long half life

If it is UMecessarily dosed more frequently, it is no longer
more cost effective than cefoxitin.

* Dose conversion:

=

cefoxitin lgm cr6h cefotetan lgm cr12h
cefoxitin 1-2gm q6h cefazolin/metronidazole q8h

=
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UPDATE ON ADVERSE DRUG REACTIONS:

Pt'eviously vve have stressed the itnportance of t'eporting Advet'se Dt'ug Reactions. We
pron"lised if you reported, "\-Ve '\-vould t•eport hack to you, Well, het'e vve are -Since the itnpletnentation of our nevv systet·n, vvhich includes a ne'\-v fortn to allo'\v fot'
more complete t'eporting as "'veU as for a faster turn-around time, vve have seen a 300%
increase in the nun1ber of t'eports. According to '\vhat "'ve kno'\v through t'ett'ospective
monitot'ing, though, "-Ve are not yet receiving repoa·ts of 100% of the reactions '\vhich at'e
occt.u'ring, but in fact have reached about 50%. The follovving represent ADR totals fot· 12
months (Apri11991 tht..ough Mat'ch 1992):
Month

Total

April '91
May '91
June '91
July '91
August '91
September '92

Month

8
8
13
13
11
18

October '91
November '91
December '91
January '92
February'92
March'92

Total
20
32
23
30
29
34

Of the reactions reported since the impletnentation of our nevv reporting system (Dec '91
through March '92), the five classes of drugs most frequently involved in reactions '\:vere:
Antimica'obials:
Anticoagulants:
Narcotic analgesics:
Cardiac Medications:
Sedative Hypnotics:

28%
10%
9%
9%
5%

We appreciate the tin1e and effort 'vhich V\ as required to increase the reporting in ot·der '
reach our pt'esent status. Through this increase in repot.. ting, '\-Ve itnpt'ove our abHtty to
follo"'v-up on specific reactions, as ''•ell as to trend t'eactions by specific agents as '\'\tell as b?
classes of agents. Our goal is not nutnerical (ie. ho'\V many reactions '\•ve have reported), but
rather to attain the ability to prevent reactions before they occur based on the kno,,dedg~
gained through your reports. We ask that you continue to he a'\ovat'e of the ianpot'tance of
drug reactions and repot"t the:n'l as they oc:c:ur.
7
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** HEALTHEAST LABORATORY NOTES **
HLA TESTING
The HLA (Histocompatibility) Lab at the Lehigh Valley Hospital-- Cedar Crest and I-78 has
been in operation for over a year and provides to the medical community of the Lehigh Valley
and surrounding area unique clinical testing opportunities. In addition to servicing the renal
transplant program, the HLA Lab offers testing which may be of value to physicians in the areas
of hematology, oncology, rheumatology, opthalmology, and endocrinology.
The following table briefly outlines the HLA tests which are currently available and indicates
some of the clinical applications for each test.

TEST

CLINICAL APPLICATION

HLA-ABC Typing

+ Type potential renal, bone marrow and platelet

HLA-DR, DQw Typing

+ Type potential renal and bone marrow recipients

HLA-B27

+ Disease Association

PRA
(Panel Reactive Antibody)
HLA Antibody Screen

+ Renal transplant
+ Platelet transfusion - when the patient has become

recipients and donors (to rule out poorly matched
donors)

and donors
+ Disease Association
i.e., DR3, DR4: Diabetes
DR2, DQwl: Narcolepsy

i.e., Ankylosing Spondylitis (and other
rheumatoid diseases)

refractory to random donor platelets

Tests which will be available in the future:
OKT-3 Antibody Screen

+ Renal and bone marrow transplant recipients

MLC
(Mixed Lymphocyte Culture)

+ Renal and bone marrow transplant recipient donor
combinations

Because of the proximity of the HLA Lab (at the Lehigh Valley Hospital) and the size of our
staff, we are able to provide to you, our customer, personable service, excellent turn-aroundtime, and convenience for your patients. If we may be of service to you, or you have additional
questions concerning the testing we offer, please contact the HLA Lab, Monday thru Friday,
7:00 a.m. to 4:00 p.m. at 215/776-8014.
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17th & Chew
Post Office Box 7017
Allentown, Pennsylvania 18105-701 i

LEHISWVAI.LEY
HOSPITAL

DATE:

April 23, 1992

TO:

Medical/Surgical Division Chiefs

FROM:

Luther V. Rhodes, III, MD
Hospital Epidemiologist

RE:

IV Therapy Update and Procedural Change

~

The following information is being relayed in an effort to keep the
Medical Staff apprised of critical issues related to IV Therapy as
well as recent policy and procedural changes.
1.

Central cannulas, A-lines, guidewires and cutdowns must be
inserted with aseptic technique, masks, hair covers, eyewear,
gloves, gowns, drapes and sterile equipment. Please see the
procedure for "Requirements for Protective Attire During
Procedures" for details.

2.

Central cannulas do not require replacement at specific intervals.

3.

Peripheral arterial lines may be left in place as long as needed,
with the understanding that lines in place longer than 4 days are
prone to colonization and ultimately, infection. Axillary
arterial catheters should not be in place beyond 4 days.

4.

When guidewires are used to change or reposition lines, they are
subject to the sa.e care require.ents as any central line (that
is, they must be used aseptically and the appropriate attire must
be worn).

5.

When a guidewire is used to exchange a catheter, the external
portion of the catheter and surrounding skin must be disinfected
with chlorhexidine or an iodophor prior to the exchange.

6.

Guidewire exchange is limited to one time per Pulmonary artery
catheter.

7.

If a first attempt at cannula insertion fails, a new (sterile)
cannula or catheter should be used for each subsequent attempt.
(This applies to peripheral IV catheters as will as CVC's and
guidewires).

8.

The upper extremity (or,· if necessary, subclavian and jugular
sites) should be used in preference to lower extremity sites for
IV cannulation in adult patients. All cannulas inserted into a
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lower extremity should be changed as soon as a satisfactory site
can be established elsewhere. Regardless of which extremity is
chosen, sites should be rotated between the left and right
extremity, if possible.
9.

If prolonged IV therapy with peripheral cannula is indicated, the
cannula should be removed and a new cannula inserted every 72

hours.

Peripheral cannulas may have to be used for longer than 72 hours if
another peripheral site cannot be found. The reason for extending
the 72 hour deadline must be documented on the progress record or
doctor's order sheet. (Physician order required.)
10. All existing peripheral IV's and CVC's should be changed with 24
hours of the patient's admission or transfer to Lehigh Valley
Hospital, unless otherwise indicated by the attending physician.
This applies to catheters inserted by pre-hospital personnel and
those inserted at transferring institutions.
Central lines which accompany patients upon transfer should be
reported to the physician who will make the decision as to whether
or not the catheters need to be removed and replaced. (Physician
order required.)
11. Wrist immobilizers should be used to stabilize all radial arterial
lines.
12. Invasive Line Protocol CVC Insertion and Maintenance. Patients
with intravenous devices should be evaluated at least once per
shift for evidence of cannula related complications by gentle
palpation of the insertion site through the intact dressing. If
the patient has an unexplained fever (T>l02°F) or there is pain or
tenderness at the insertion site, the dressing should be removed
and the IV site inspected directly.
Fever work-up in the absence of an obvious infection source,
should include exchanging and culturing all indwelling catheters
provided the skin site appears healthy.
Summary Statement
a.

CVC's are left in place and not changed until indicated.

b.

CVC's are changed by guidewire technique under the following
conditions:
1.
2.
3.
4.

c.

Catheter malfunction
CVC to PAC intercoversion
Positive blood culture since catheter last changed
Septic clinical pattern without obvious etiology.

CVC's are changed with a fresh stick under the following
conditions:
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1.

Skin infection at insertion site:
a)

b)

c)

purulent drainage at skin puncture site.
cellulitis at skin puncture site.
erythema at skin puncture site and a positive skin site
culture.

2.

A positive line culture.

3.

Documented catheter related sepsis (a positive blood culture
and catheter culture with the same organism).
(More than 15 cfu/ml is considered a positive catheter
culture.)

LVR/lf
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